Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

PartnershipUpdated on 25 January 2026

BIOTECH: Finding funding to develop Novel Neuropsychiatric Drugs via Computational Multi-Target Drug Design

Dorit Cohen

Founder & CEO at ReSynapse Therapeutics

Nes Ziona, Israel

About

We would like to find potential strategic partnership for funding a co-development of Novel Neuropsychiatric Drugs via Computational Multi-Target Drug Design, aiming for treatment-resistant depression patients.

Similar opportunities